Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-038791

EVP, Research & CSO sold 14,920 shares at an average $44.64 ($666,058)

  • EVP, Research & CSO acquired 14,920 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-06-23 Option exercise +5,560 $1.53 $8,507 5,560 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2020-06-23 Sale −5,560 $38.99 $216,778 0 D: show line 2 in the form
Virgin Herbert EVP, Research & CSO 2020-06-24 Option exercise +9,360 $1.53 $14,321 9,360 D: show line 3 in the form
Virgin Herbert EVP, Research & CSO 2020-06-24 Sale −9,360 $48.00 $449,280 0 D: show line 4 in the form
Open-market sales · 14,920 sh · avg $44.64 · $666,058

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-06-23 Option exercise · Stock Option (Right to Buy) −5,560 533,315 D: show line 5 in the form
Virgin Herbert EVP, Research & CSO 2020-06-24 Option exercise · Stock Option (Right to Buy) −9,360 523,955 D: show line 6 in the form
Loading xslF345X03/doc4.xml…